Dale A. Sander

CIK: 0001878193

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HUMA

Humacyte, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

HUMA
Humacyte, Inc.
May 18, 2026
Sale(S)
Direct
45.9K shares at avg. $0.90$41K
HUMA
Humacyte, Inc.
Nov 16, 2025
Award(A)
Direct
311.1K shares-
HUMA
Humacyte, Inc.
Apr 10, 2025
Purchase(P)
Indirect
20K shares at avg. $1.53$31K
HUMA
Humacyte, Inc.
Jan 21, 2025
Award(A)
Stock Options (right to buy)
Direct
283.1K shares-
HUMA
Humacyte, Inc.
Dec 19, 2024
Award(A)
Stock Options (right to buy)
Direct
525 shares-

		Type	Shares	Price		Ownership
May 18, 2026	HUMA Humacyte, Inc.	Sale(S)	45,887	$0.90	$41,147	Direct
Nov 16, 2025	HUMA Humacyte, Inc.	Award(A)	311,100	-	-	Direct
Apr 10, 2025	HUMA Humacyte, Inc.	Purchase(P)	20,000	$1.53	$30,600	Indirect
Jan 21, 2025	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	283,101	-	-	Direct
Dec 19, 2024	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	525	-	-	Direct

1-5 of 5 transactions

About Sander Dale A.

Sander Dale A. (SEC CIK 0001878193) files insider reports with the SEC as CFO and Chief Corp. Deve. Off. of Humacyte, Inc. (HUMA).

Signal8 holds 5 ownership filings by Sander Dale A., all Form 4s, filed between Dec 20, 2024 and May 20, 2026. Those filings report 5 transactions, from Dec 19, 2024 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sander Dale A.'s filings is in DURHAM, NC.

Recent filings by Sander Dale A.

May 18, 2026: Open-market sale of HUMA shares (Form 4, code S).
Nov 16, 2025: Grant or award of HUMA shares (Form 4, code A).
Apr 10, 2025: Open-market purchase of HUMA shares (Form 4, code P).
Jan 21, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
Dec 19, 2024: Grant or award of HUMA derivative securities (Form 4, code A).

Other insiders filing for Humacyte, Inc. (HUMA)

COWARD D SCOTT, Director
Kuznik Paul Brian, Director
Jones Keith Anthony, Director
Windham-Bannister Susan Richards, Director
Constantino Michael T., Director
Wallace Max N., Director

How to read Form 4 transaction codes